CIK 0001129928 · Non-accelerated filer<br>Smaller reporting company
ONCOLYTICS BIOTECH INC
Sign in to watch- Ticker
- ONCY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 980541667
- Phone
- 4036707377
- Business address
- SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Heineman Thomas Charles Chief Medical Officer | Purchase | +12,132 | $0.83 | $10K | 282,818 |
| 2026-02-12 | Hagerman Allison VP, Product Development | Purchase | +10,000 | $0.83 | $8K | 115,059 |
| 2026-02-12 | Brown Deborah Margaret Director | Purchase | +25,000 | $0.85 | $21K | 109,851 |
| 2026-02-12 | Andrews Patricia S Director | Purchase | +35,400 | $0.86 | $30K | 78,128 |
| 2026-02-11 | Seizinger Bernd R. Director | Purchase | +60,000 | $0.83 | $50K | 526,991 |
| 2026-02-11 | Kelly Jared Chief Executive Officer | Purchase | +5,600 | $0.84 | $5K | 79,500 |
| 2026-02-11 | Aromando Andrew Chief Business Officer | Purchase | +29,600 | $0.86 | $25K | 55,100 |
| 2026-01-16 | Seizinger Bernd R. Director | Purchase | +100,000 | $1.04 | $104K | 466,991 |
Page 2 of 2 · 28 trades